ReviewCurrent diabetes reports2020

Assessment of Risks and Benefits of Beta Cell Replacement Versus Automated Insulin Delivery Systems for Type 1 Diabetes.

Peter Senior et al.PubMed ↗Publisher ↗

No numbers read from the abstract.